Augmenix

Provider of a hydrogel spacer for prostate cancer radiation therapy

placeWaltham, Massachusetts, United States calendar_todayFounded 2008 groups153 employees language augmenix.com

Registered entities

Social engagement

Social engagement: 45.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Incept, Versant Ventures, Pinnacle Ventures.

Investor typeCountShare
Venture capital571%
Bank & private debt114%
Other / undisclosed114%

Recent activity

31 Mar 2026
Product launch
AMS 700TM Inflatable Penile Prosthesis
20 Feb 2026
Event
World Meeting on Sexual Medicine 2026
Coming soon